Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition
It's important to note that hair loss (alopecia) is listed as an adverse reaction in the Summary of Product Characteristics (SmPC) for semaglutide 2.4 mg (Wegovy), though it is not listed as a common side effect for other GLP-1 medications such as Ozempic, Saxenda, or Trulicity
If you miss your injection window by a few hours, taking it as soon as you remember is safe
The practical takeaway is that whether a GLP-1 medication is appropriate is a product-specific, individual decision
Diabetes Investig ., 7 , 777785